HK1211479A1 - Prophylactic or therapeutic drug for constipation - Google Patents

Prophylactic or therapeutic drug for constipation

Info

Publication number
HK1211479A1
HK1211479A1 HK15112295.0A HK15112295A HK1211479A1 HK 1211479 A1 HK1211479 A1 HK 1211479A1 HK 15112295 A HK15112295 A HK 15112295A HK 1211479 A1 HK1211479 A1 HK 1211479A1
Authority
HK
Hong Kong
Prior art keywords
constipation
prophylactic
therapeutic drug
therapeutic
drug
Prior art date
Application number
HK15112295.0A
Other languages
English (en)
Chinese (zh)
Inventor
山本大輔
井尾房代
山本浩二
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of HK1211479A1 publication Critical patent/HK1211479A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15112295.0A 2013-02-04 2015-12-15 Prophylactic or therapeutic drug for constipation HK1211479A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013019754 2013-02-04
PCT/JP2014/052465 WO2014119787A1 (fr) 2013-02-04 2014-02-03 Médicament à visée prophylactique ou thérapeutique pour la constipation

Publications (1)

Publication Number Publication Date
HK1211479A1 true HK1211479A1 (en) 2016-05-27

Family

ID=51262485

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112295.0A HK1211479A1 (en) 2013-02-04 2015-12-15 Prophylactic or therapeutic drug for constipation

Country Status (18)

Country Link
US (1) US10022389B2 (fr)
EP (1) EP2952206B1 (fr)
JP (1) JP5807767B2 (fr)
KR (1) KR102078433B1 (fr)
CN (1) CN104955481B (fr)
AU (1) AU2014213251B2 (fr)
BR (1) BR112015017541A2 (fr)
CA (1) CA2899834C (fr)
ES (1) ES2694110T3 (fr)
HK (1) HK1211479A1 (fr)
IL (1) IL240192A (fr)
MX (1) MX346453B (fr)
MY (1) MY176162A (fr)
PH (1) PH12015501696B1 (fr)
RU (1) RU2648467C2 (fr)
SG (2) SG10201700267PA (fr)
TW (1) TWI659739B (fr)
WO (1) WO2014119787A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019142774A (ja) * 2016-06-20 2019-08-29 大正製薬株式会社 腸内環境改善剤

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2830424C3 (de) 1978-07-11 1982-04-15 Bayer Ag, 5090 Leverkusen alpha -Glucosidase-Inhibitoren
US5651988A (en) 1995-08-18 1997-07-29 Xyrofin Oy Combination osmotic and bulk forming laxatives
NZ538117A (en) 2002-08-08 2007-01-26 Kissei Pharmaceutical Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
JP2004137245A (ja) 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
JP4606876B2 (ja) 2002-08-27 2011-01-05 キッセイ薬品工業株式会社 ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途
CA2507665A1 (fr) 2002-12-04 2004-06-17 Kissei Pharmaceutical Co., Ltd. Prevention ou traitement de maladies dues a l'hyperglycemie
DE102004028241B4 (de) 2004-06-11 2007-09-13 Sanofi-Aventis Deutschland Gmbh Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
TWI387454B (zh) 2004-09-02 2013-03-01 Sucampo Ag 治療胃腸道疾病之方法及組成物
NZ573687A (en) * 2006-05-19 2010-10-29 Taisho Pharmaceutical Co Ltd C-phenyl glycitol compound for the treatment of diabetes
JP5152519B2 (ja) 2006-06-29 2013-02-27 大正製薬株式会社 Ｃ−フェニル１−チオグルシト−ル化合物
TW200817424A (en) 2006-08-04 2008-04-16 Daiichi Sankyo Co Ltd Benzylphenyl glucopyranoside derivatives
TWI499414B (zh) 2006-09-29 2015-09-11 Lexicon Pharmaceuticals Inc 鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法
AU2007332476A1 (en) 2006-12-14 2008-06-19 Taisho Pharmaceutical Co., Ltd. 1-phenyl 1-thio-D-glucitol derivative
GB2447067A (en) 2007-02-20 2008-09-03 Branko R Babic Alteration of osmotic gradients by polyhydroxy compounds
RU2482122C2 (ru) 2007-12-27 2013-05-20 Киссеи Фармасьютикал Ко., Лтд. Моносебацинат производного пиразола
CA2725230C (fr) 2008-04-16 2016-05-17 Kissei Pharmaceutical Co., Ltd. Hemifumarate d'un derive de pyrazole
ES2397086T3 (es) * 2009-02-23 2013-03-04 Taisho Pharmaceutical Co., Ltd. Compuestos de 4-isopropilfenil glucitol como inhibidores de SGLT1
JP2013224263A (ja) 2010-08-19 2013-10-31 Taisho Pharmaceutical Co Ltd ４−イソプロピルフェニルグルシトール化合物
AU2011291709B2 (en) 2010-08-20 2014-03-27 Taisho Pharmaceutical Co., Ltd. Crystal form of 4-isopropylphenyl glucitol compound and process for production thereof
WO2012023600A1 (fr) 2010-08-20 2012-02-23 大正製薬株式会社 Composé 4-isopropyl-6-méthoxyphényl glucitol
AR087701A1 (es) 2011-08-31 2014-04-09 Japan Tobacco Inc Derivados de pirazol con actividad inhibidora de sglt1
ES2601127T3 (es) 2012-05-07 2017-02-14 Kissei Pharmaceutical Co., Ltd. Derivado de pirazol y su uso con fines médicos
CA2891773C (fr) 2012-11-20 2021-01-19 Lexicon Pharmaceuticals, Inc. Inhibiteurs du cotransporteur sodium glucose 1

Also Published As

Publication number Publication date
US20150374735A1 (en) 2015-12-31
RU2015137671A (ru) 2017-03-10
ES2694110T3 (es) 2018-12-18
EP2952206A4 (fr) 2016-06-15
IL240192A (en) 2017-03-30
MY176162A (en) 2020-07-24
EP2952206A1 (fr) 2015-12-09
MX2015010029A (es) 2015-10-30
KR20150112949A (ko) 2015-10-07
TWI659739B (zh) 2019-05-21
IL240192A0 (en) 2015-09-24
JPWO2014119787A1 (ja) 2017-01-26
CA2899834A1 (fr) 2014-08-07
AU2014213251A1 (en) 2015-08-27
CA2899834C (fr) 2020-09-01
CN104955481B (zh) 2017-10-24
SG10201700267PA (en) 2017-02-27
BR112015017541A2 (pt) 2017-07-11
SG11201506047PA (en) 2015-09-29
PH12015501696A1 (en) 2015-10-12
EP2952206B1 (fr) 2018-10-24
WO2014119787A1 (fr) 2014-08-07
MX346453B (es) 2017-03-17
KR102078433B1 (ko) 2020-02-17
AU2014213251B2 (en) 2017-07-20
JP5807767B2 (ja) 2015-11-10
US10022389B2 (en) 2018-07-17
RU2648467C2 (ru) 2018-03-26
PH12015501696B1 (en) 2015-10-12
TW201517903A (zh) 2015-05-16
CN104955481A (zh) 2015-09-30

Similar Documents

Publication Publication Date Title
HRP20180684T1 (hr) Kombinacija lijekova
ZA201507576B (en) Pharmaceutical combination drug
GB201308440D0 (en) Therapeutic
HK1223833A1 (zh) 藥物劑型
EP2968179A4 (fr) Formes galéniques pharmaceutiques à libération contrôlée
ZA201600027B (en) Pharmaceutical preparation
EP3046556A4 (fr) Polythérapie médicamenteuse
GB201318668D0 (en) Sonosensitive therapeutic
HK1220633A1 (zh) 含有氨基吡唑衍生物的藥物製劑
HK1211479A1 (en) Prophylactic or therapeutic drug for constipation
ZA201506465B (en) Pharmaceutical preparation
GB201320786D0 (en) Medicament
GB201316662D0 (en) Pharmaceutical Combination
GB201305073D0 (en) Therapeutic means

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230131